Table 2 Treatment and glycemic control in the diabetic patient population (N = 186)
Characteristic | Patients % (n/N) |
|---|---|
Metformin | |
Yes | 59.7 (111/186) |
No | 40.3 (75/186) |
Glibenclamide | |
Yes | 32.3 (60/186) |
No | 67.7 (126/186) |
Insulin | |
Yes | 11.3 (21/186) |
No | 88.7 (165/186) |
Other antidiabetic medication | |
Yes | 5.4 (10/186) |
No | 94.6 (176/186) |
Basal Fasting Glucose | |
Mean (± S.D.) | 170 (78.5) |
Range | 74–604 |
Glycemic Control (n = 185)a | |
Proper (<130 mg/dLb) | 31.2 (58/185) |
Improper (≥130 mg/dLb) | 68.8 (127/185) |